Uterine and vaginal insemination optimised in brushtail possums (Trichosurus vulpecula) superovulated with pregnant mare serum gonadotrophin and porcine luteinising hormone.
Artificial insemination of brushtail possums (Trichosurus vulpecula) is being developed as an assisted breeding model for endangered marsupials, as well as a bioassay for testing fertility control vaccines to manage overabundant populations. Procedures were optimised in animals superovulated with pregnant mare serum gonadotrophin (PMSG) and porcine luteinising hormone (pLH). Of three intervals examined, yields were maximal following uterine insemination at 27-29.5 h after pLH treatment (four eggs, two to three embryos per female). Compared with no insemination, uterine-inseminated animals ovulated 30-36 h rather than 28-34 h after pLH treatment. For the vaginal route, yields were maximal following insemination at 10-13 h after pLH treatment (six to seven eggs, four embryos per female) than at five other intervals, and when using acclimatised females during the autumn breeding season. This protocol was suitable for testing fertility control vaccines in April-June and was influenced by the housing location of animals, the presence of an active corpus luteum and PMSG batch, but not other factors (year of trial, Freund's adjuvant treatment, changes in bodyweight, dose of PMSG kg(-1)). Embryos developed to the eight- to 16-cell or unilaminar blastocyst stage after uterine or vaginal insemination, respectively. With the timing of artificial insemination optimised, new methods to synchronise or induce oestrus and ovulation are required to achieve year-round testing of fertility control vaccines or birth of offspring.
Molinia
F C
FC
National Research Centre for Possum Biocontrol at Landcare Research, PO Box 40, Lincoln 7640, New Zealand. moliniaf@landcareresearch.co.nz
Myers
J V
JV
Glazier
A M
AM
Duckworth
J A
JA
Rodger
J C
JC
D000818:Animals; D047108:Embryonic Development; D005260:Female; D006064:Gonadotropins, Equine / Q000494:pharmacology*; D007315:Insemination, Artificial / Q000379:methods*; D008098:Litter Size / Q000187:drug effects; D007986:Luteinizing Hormone / Q000494:pharmacology*; D010060:Ovulation / Q000187:drug effects; D010062:Ovulation Induction / Q000379:methods; D011247:Pregnancy; D013480:Superovulation; D013552:Swine; D013997:Time Factors; D048330:Trichosurus / Q000502:physiology*; D014599:Uterus / Q000502:physiology; D022642:Vaccines, Contraceptive / Q000008:administration & dosage / Q000037:antagonists & inhibitors; D014621:Vagina / Q000502:physiology
D006064:Gonadotropins, Equine; D022642:Vaccines, Contraceptive; D007986:Luteinizing Hormone